Candriam SCA’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-20,674
| Closed | -$1.56M | – | 701 |
|
|
2026
Q1 | $1.56M | Sell |
20,674
-2,725
| -12% | -$205K | 0.01% | 551 |
|
|
2025
Q4 | $1.74M | Sell |
23,399
-375,878
| -94% | -$27.5M | 0.01% | 520 |
|
|
2025
Q3 | $26.9M | Hold |
399,277
| – | – | 0.14% | 143 |
|
|
2025
Q2 | $26M | Sell |
399,277
-30,864
| -7% | -$1.85M | 0.15% | 130 |
|
|
2025
Q1 | $26.6M | Sell |
430,141
-514,191
| -54% | -$34.1M | 0.17% | 128 |
|
|
2024
Q4 | $68.1M | Sell |
944,332
-193,047
| -17% | -$15.1M | 0.39% | 55 |
|
|
2024
Q3 | $92.6M | Sell |
1,137,379
-206,207
| -15% | -$16.5M | 0.53% | 38 |
|
|
2024
Q2 | $99.8M | Sell |
1,343,586
-28,331
| -2% | -$2.12M | 0.6% | 35 |
|
|
2024
Q1 | $107M | Buy |
1,371,917
+37,878
| +3% | +$2.82M | 0.68% | 31 |
|
|
2023
Q4 | $95.3M | Buy |
1,334,039
+41,307
| +3% | +$2.88M | 0.66% | 29 |
|
|
2023
Q3 | $89.7M | Buy |
1,292,732
+25,037
| +2% | +$1.89M | 0.64% | 28 |
|
|
2023
Q2 | $103M | Buy |
1,267,695
+10,054
| +0.8% | +$822K | 0.74% | 23 |
|
|
2023
Q1 | $93.4M | Buy |
1,257,641
+194,125
| +18% | +$15.6M | 0.65% | 27 |
|
|
2022
Q4 | $79.6M | Buy |
1,063,516
+1,736
| +0.2% | +$124K | 0.54% | 34 |
|
|
2022
Q3 | $68.5M | Buy |
1,061,780
+165,226
| +18% | +$11.4M | 0.48% | 43 |
|
|
2022
Q2 | $62.1M | Buy |
896,554
+30,479
| +4% | +$2.26M | 0.51% | 43 |
|
|
2022
Q1 | $66.5M | Sell |
866,075
-273,099
| -24% | -$19.6M | 0.45% | 52 |
|
|
2021
Q4 | $87.2M | Buy |
1,139,174
+603,846
| +113% | +$44.4M | 0.56% | 43 |
|
|
2021
Q3 | $39.5M | Buy |
535,328
+139,145
| +35% | +$10.4M | 0.27% | 92 |
|
|
2021
Q2 | $26.4M | Sell |
396,183
-559,548
| -59% | -$37.4M | 0.18% | 136 |
|
|
2021
Q1 | $66.9M | Sell |
955,731
-27
| -0% | -$2.05K | 0.56% | 36 |
|
|
2020
Q4 | $69.6M | Buy |
955,758
+125,023
| +15% | +$8.83M | 0.55% | 36 |
|
|
2020
Q3 | $55.2M | Buy |
830,735
+157,737
| +23% | +$9.98M | 0.52% | 37 |
|
|
2020
Q2 | $38.4M | Buy |
672,998
+317,739
| +89% | +$15.6M | 0.4% | 54 |
|
|
2020
Q1 | $18.1M | Buy |
355,259
+99
| +0% | +$4.71K | 0.2% | 116 |
|
|
2019
Q4 | $18.5M | Buy |
355,160
+139,296
| +65% | +$6.94M | 0.2% | 116 |
|
|
2019
Q3 | $10.9M | Buy |
215,864
+59,295
| +38% | +$2.92M | 0.14% | 166 |
|
|
2019
Q2 | $7.49M | Buy |
156,569
+84,328
| +117% | +$3.9M | 0.09% | 241 |
|
|
2019
Q1 | $3.5M | Buy |
72,241
+59,981
| +489% | +$2.7M | 0.04% | 390 |
|
|
2018
Q4 | $504K | Buy |
+12,260
| New | +$503K | 0.01% | 684 |
|
|
2017
Q3 | – | Sell |
-79,542
| Closed | -$3.61M | – | 733 |
|
|
2017
Q2 | $3.61M | Sell |
79,542
-101,323
| -56% | -$4.47M | 0.07% | 336 |
|
|
2017
Q1 | $7.7M | Sell |
180,865
-29,919
| -14% | -$1.22M | 0.15% | 173 |
|
|
2016
Q4 | $8.46M | Buy |
210,784
+50,247
| +31% | +$1.94M | 0.19% | 137 |
|
|
2016
Q3 | $6.23M | Sell |
160,537
-150,426
| -48% | -$5.68M | 0.15% | 163 |
|
|
2016
Q2 | $10.8M | Buy |
+310,963
| New | +$10.8M | 0.28% | 93 |
|
Other funds holding HOLX
Candriam SCA's HOLX Position: Q2 2026 in Review
Candriam SCA sold out of Hologic (HOLX) in Q2 2026, closing a stake of 20,674 shares — an estimated $1.56M sold.
Candriam SCA first reported a position in HOLX in Q2 2016 and held it in 35 quarters. The position peaked at $107M in Q1 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Candriam SCA reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Candriam SCA sold 20,674 Hologic shares in Q2 2026, an estimated $1.56M.
- Candriam SCA first reported a position in Hologic in Q2 2016 and held it in 35 quarters.
- Candriam SCA's Hologic position peaked at $107M in Q1 2024.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.